Drugmakers and pharmacy disagree over who gets to make the drugs
The US Food and Drug Administration (FDA) has issued a warning to a California pharmacy over allegations that it made a copy of Novo Nordisk’s obesity drug ‘Ozempic’. This comes after Novo Nordisk asked the FDA to add semaglutide, the key ingredient in Ozempic, to its list of drugs deemed too difficult to compound safely. Novo Nordisk said it has filed several lawsuits against compounders.
Soon there will be an over-the-counter birth control pill in the US
The US Food and Drug Administration (FDA) on Wednesday approved over-The-Counter (OTC) birth control pill Opill for sale at retail stores without a prescription. “Today we begin shipping O Pill to our retailers for their bricks-and-mortar stores,” FDA’s deputy commissioner said. The pill is more effective than condoms, spermicides and other nonprescription methods, according to research.